Clinical Trial Update: Sotatercept on Central Cardiopulmonary Performance and Peripheral Oxygen Transport During Exercise in Pulmonary Arterial Hypertension [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial update summarizes results from a study of sotatercept assessing central cardiopulmonary performance and peripheral oxygen transport …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Sotatercept (sotatercept)

Snippet

Sponsor: Mayo Clinic | Conditions: Pulmonary Arterial Hypertension | Phase 4 | Status: COMPLETED